{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04024631",
            "orgStudyIdInfo": {
                "id": "831865"
            },
            "organization": {
                "fullName": "University of Pennsylvania",
                "class": "OTHER"
            },
            "briefTitle": "Phenotyping Genetic Risk for Type 2 Diabetes",
            "officialTitle": "Phenotyping Children and Adults With Possible High or Low Genetic Risk for Type 2 Diabetes",
            "therapeuticArea": [
                "Rare Diseases",
                "Endocrinology"
            ],
            "study": "phenotyping-genetic-risk-for-type-diabetes"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2019-06-17",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-06-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-06-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2019-07-13",
            "studyFirstSubmitQcDate": "2019-07-16",
            "studyFirstPostDateStruct": {
                "date": "2019-07-18",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-03-03",
            "lastUpdatePostDateStruct": {
                "date": "2023-03-06",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Jessica R.Wilson, MD, MS",
                "investigatorTitle": "Instructor in Medicine",
                "investigatorAffiliation": "University of Pennsylvania"
            },
            "leadSponsor": {
                "name": "University of Pennsylvania",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study tests the hypothesis that non-diabetic individuals with a high genetic risk score for type 2 diabetes have impaired glucose tolerance and insulin resistance compared to those with a low genetic risk score for type 2 diabetes.",
            "detailedDescription": "The study team will recruit individuals based on genetic risk score for type 2 diabetes from the biobank populations who have agreed to be recontacted for future research. Each participant will undergo a frequently sampled four-hour oral glucose tolerance test and whole body DXA scan (dual-energy X-ray absorptiometry) in addition to baseline laboratory and history assessment."
        },
        "conditionsModule": {
            "conditions": [
                "Diabetes Mellitus, Type 2",
                "Genetics"
            ],
            "keywords": [
                "polygenic risk for type 2 diabetes"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "interventionModelDescription": "cross sectional",
                "primaryPurpose": "OTHER",
                "maskingInfo": {
                    "masking": "NONE",
                    "maskingDescription": "Data analyses (including by outcomes assessors and investigators) will be de-identified, and individuals performing laboratory analyses and DXA interpretation will be blinded to polygenic risk score for type 2 diabetes. Participants and nursing staff will not be informed of polygenic risk score at the time of the study."
                }
            },
            "enrollmentInfo": {
                "count": 100,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Phenotyping",
                    "type": "OTHER",
                    "description": "All participants will undergo a four-hour frequently sampled oral glucose tolerance test in which they will ingest a 75g glucose beverage (intervention) within five minutes and have samples collected at baseline and for four hours after.\n\nThey will also undergo a whole body DXA (intervention) during the study day.",
                    "interventionNames": [
                        "Other: 75g glucose beverage (Glucola, Trutol, or similar brand)",
                        "Other: DXA, whole body"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "75g glucose beverage (Glucola, Trutol, or similar brand)",
                    "description": "Subjects will present fasting to the study day and ingest the glucose beverage during the oral glucose tolerance test.",
                    "armGroupLabels": [
                        "Phenotyping"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "DXA, whole body",
                    "description": "Subjects will undergo a whole body DXA scan for assessment of adiposity index and body fat distribution.",
                    "armGroupLabels": [
                        "Phenotyping"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Glucose response to an oral glucose load",
                    "description": "Glucose area under the curve after the 75g glucose beverage",
                    "timeFrame": "samples will be collected over four hours and these results will be used to calculate area under the curve"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Visceral adiposity index",
                    "description": "DXA whole body scan visceral adiposity index",
                    "timeFrame": "DXA scan will be obtained on the same day as the oral glucose test and will be completed in less than 30 minutes"
                },
                {
                    "measure": "HOMA-IR",
                    "description": "Insulin resistance estimate",
                    "timeFrame": "calculated from baseline fasting insulin and glucose levels"
                },
                {
                    "measure": "Disposition index",
                    "description": "product of insulin sensitivity and amount of insulin released; calculated using mixed modeling techniques",
                    "timeFrame": "samples will be collected over four hours after the 75g glucose beverage and these results will be used for mixed modeling"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Age 10-70 years\n* Prior participant of the UPenn Biobank or Center for Applied Genomics Biobank and agreed to be recontacted for future research.\n* Adults with BMI 25kg/m2 or higher, children and adolescents with BMI 85th percentile or higher\n\nExclusion Criteria:\n\n* prior diagnosis of type 1, type 2, or secondary diabetes\n* use of medications that would impact glucose and insulin response such as steroids, metformin or other anti-diabetic medication\n* acute illness that may impact insulin and glucose dynamics\n* pregnancy\n* hypothalamic obesity or related genetic disorder of metabolism\n* recent systemic chemotherapy use\n* gastrointestinal impairment or surgery that may impact absorption\n* anemia\n* major organ system illness or any underlying condition requiring regular medication or treatment that could make implementation of the protocol or interpretation of the study results difficult\n* inability to comply with study protocol",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "10 Years",
            "maximumAge": "70 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Jessica R Wilson, MD, MS",
                    "role": "CONTACT",
                    "phone": "215 898-3389",
                    "email": "jessica.wilson3@uphs.upenn.edu"
                },
                {
                    "name": "Esther Oyerinde",
                    "role": "CONTACT",
                    "email": "esther.oyerinde@pennmedicine.upenn.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Jessica R Wilson, MD, MS",
                    "affiliation": "University of Pennsylvania",
                    "role": "PRINCIPAL_INVESTIGATOR"
                },
                {
                    "name": "Lorraine Levitt Katz, MD",
                    "affiliation": "Childrens Hospital of Philadelphia",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Childrens Hospital of Philadelphia",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jessica R Wilson, MD, MS",
                            "role": "CONTACT",
                            "phone": "215-898-3389",
                            "email": "jessica.wilson3@uphs.upenn.edu"
                        },
                        {
                            "name": "Esther Oyerinde",
                            "role": "CONTACT",
                            "email": "esther.oyerinde@pennmedicine.upenn.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "University of Pennsylvania",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jessica R Wilson, MD, MS",
                            "role": "CONTACT",
                            "phone": "215-898-3389",
                            "email": "jessica.wilson3@uphs.upenn.edu"
                        },
                        {
                            "name": "Esther Oyerinde",
                            "role": "CONTACT",
                            "email": "esther.oyerinde@pennmedicine.upenn.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003920",
                    "term": "Diabetes Mellitus"
                },
                {
                    "id": "D000003924",
                    "term": "Diabetes Mellitus, Type 2"
                }
            ],
            "ancestors": [
                {
                    "id": "D000044882",
                    "term": "Glucose Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7119",
                    "name": "Diabetes Mellitus, Type 2",
                    "asFound": "Diabetes Mellitus, Type 2",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7115",
                    "name": "Diabetes Mellitus",
                    "asFound": "Diabetes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M25403",
                    "name": "Glucose Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}